Middle East Pharmaceutical Industries Co (SAU:4016) Institutional Ownership: 0.96% (As of Aug. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SAU:4016 Middle East Pharmaceutical Industries Co SAU:4016
21 GF Score
Price ﷼68.00
! 3 Warning Signs
View Full Analysis

What is Middle East Pharmaceutical Industries Co Institutional Ownership?

Middle East Pharmaceutical Industries Co SAU:4016 +4.45% 21 Institutional Ownership is 0.96% as of Aug. 31, 2026. GuruFocus rates SAU:4016 with a GF Score™ of 21/100. The stock has 3 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Middle East Pharmaceutical Industries Co's institutional ownership is 0.96%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Middle East Pharmaceutical Industries Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Middle East Pharmaceutical Industries Co's Float Percentage Of Total Shares Outstanding is 0.00%.

Middle East Pharmaceutical Industries Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Middle East Pharmaceutical Industries Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Middle East Pharmaceutical Industries Co Institutional Ownership Chart

Middle East Pharmaceutical Industries Co Historical Data

The historical data trend for Middle East Pharmaceutical Industries Co can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 0.36 0.44 0.47 0.48 0.50 0.46 0.48 0.75 0.82 0.96
SAU:4016
21GF Score
Middle East Pharmaceutical Industries Co SAU:4016
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Middle East Pharmaceutical Industries Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.96% mean?
Middle East Pharmaceutical Industries Co (SAU:4016) has a Institutional Ownership of 0.96% as of Aug. 31, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Middle East Pharmaceutical Industries Co and its competitors.
Is Middle East Pharmaceutical Industries Co's Institutional Ownership too high?
Middle East Pharmaceutical Industries Co's current Institutional Ownership is 0.96%. Overall, Middle East Pharmaceutical Industries Co has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Middle East Pharmaceutical Industries Co's Institutional Ownership compare to ZTS and UTHR?
Middle East Pharmaceutical Industries Co's Institutional Ownership of 0.96% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Middle East Pharmaceutical Industries Co and its competitors. Middle East Pharmaceutical Industries Co's current Institutional Ownership is 0.96%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Middle East Pharmaceutical Industries Co stock overvalued right now?
Middle East Pharmaceutical Industries Co (SAU:4016) has a current Institutional Ownership of 0.96%. The current Institutional Ownership is 0.96%. Middle East Pharmaceutical Industries Co's overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Middle East Pharmaceutical Industries Co (SAU:4016), the current Institutional Ownership is 0.96% as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Middle East Pharmaceutical Industries Co Business Description

Address 8146 King Muhammad V, Sulaimaniyah, P.O. Box 4180, Riyadh, SAU, 11491
Middle East Pharmaceutical Industries Co is a holding company engaged in manufacturing medicines, medicated and non-medicated creams and gels. The company operates in Private, Public, and Export segments. Geographically, it generates the majority of its revenue from Saudi Arabia.
21GF Score

Get the complete analysis for SAU:4016

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼68.00
Price